CYTOGEN Trademark

Trademark Overview


On Tuesday, July 5, 2022, a trademark application was filed for CYTOGEN with the United States Patent and Trademark Office. The USPTO has given the CYTOGEN trademark a serial number of 97489712. The federal status of this trademark filing is PUBLICATION/ISSUE REVIEW COMPLETE as of Wednesday, July 17, 2024. This trademark is owned by Cytogen, Inc.. The CYTOGEN trademark is filed in the Pharmaceutical Products category with the following description:

Chemical preparations for testing blood for medical purposes; Reagents for blood grouping for medical purposes; Solutions for medical use in storing and treating cells, blood and blood components; Medical diagnostic reagents and assays for testing of body fluids; Biological preparations for the treatment of cancer; Diagnostic biomarker reagents for medical purposes; Diagnostic preparations for medical purposes; Diagnostic preparations for veterinary purposes; Mixed biological preparations for the prevention and treatment of infectious diseases; Diagnostic agents and preparations for medical purposes
cytogen

General Information


Serial Number97489712
Word MarkCYTOGEN
Filing DateTuesday, July 5, 2022
Status681 - PUBLICATION/ISSUE REVIEW COMPLETE
Status DateWednesday, July 17, 2024
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, August 20, 2024

Trademark Statements


Goods and ServicesChemical preparations for testing blood for medical purposes; Reagents for blood grouping for medical purposes; Solutions for medical use in storing and treating cells, blood and blood components; Medical diagnostic reagents and assays for testing of body fluids; Biological preparations for the treatment of cancer; Diagnostic biomarker reagents for medical purposes; Diagnostic preparations for medical purposes; Diagnostic preparations for veterinary purposes; Mixed biological preparations for the prevention and treatment of infectious diseases; Diagnostic agents and preparations for medical purposes
Translation of Words in MarkThe wording "Cytogen" has no meaning in a foreign language.

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateMonday, July 25, 2022
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameCytogen, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressSeoul 05854
KR

Trademark Events


Event DateEvent Description
Friday, July 8, 2022NEW APPLICATION ENTERED
Monday, July 25, 2022NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Tuesday, April 18, 2023ASSIGNED TO EXAMINER
Wednesday, April 19, 2023SUSPENSION LETTER WRITTEN
Wednesday, April 19, 2023LETTER OF SUSPENSION E-MAILED
Wednesday, April 19, 2023NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
Tuesday, October 24, 2023SUSPENSION INQUIRY WRITTEN
Tuesday, October 24, 2023INQUIRY TO SUSPENSION E-MAILED
Tuesday, October 24, 2023NOTIFICATION OF INQUIRY AS TO SUSPENSION E-MAILED
Monday, January 8, 2024TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED
Monday, January 8, 2024CORRESPONDENCE RECEIVED IN LAW OFFICE
Tuesday, January 9, 2024TEAS/EMAIL CORRESPONDENCE ENTERED
Tuesday, January 23, 2024NON-FINAL ACTION WRITTEN
Tuesday, January 23, 2024NON-FINAL ACTION E-MAILED
Tuesday, January 23, 2024NOTIFICATION OF NON-FINAL ACTION E-MAILED
Friday, January 26, 2024TEAS RESPONSE TO OFFICE ACTION RECEIVED
Tuesday, July 16, 2024TEAS/EMAIL CORRESPONDENCE ENTERED
Tuesday, July 16, 2024APPROVED FOR PUB - PRINCIPAL REGISTER
Tuesday, July 16, 2024CORRESPONDENCE RECEIVED IN LAW OFFICE
Tuesday, July 16, 2024ASSIGNED TO LIE
Wednesday, July 31, 2024NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED